No Prognostic or Molecular Disparity Between Synchronous and Metachronous Metastases in Differentiated Thyroid Cancer: Insight From Middle Eastern Cohort
CompletedOBSERVATIONAL
Enrollment
178
Participants
Timeline
Start Date
January 1, 1988
Primary Completion Date
December 31, 2018
Study Completion Date
December 31, 2024
Conditions
Differentiated Thyroid Cancer
Interventions
OTHER
No additional drugs(control Group)
No intervention
All Listed Sponsors
lead
King Faisal Specialist Hospital & Research Center
OTHER
NCT07115810 - No Prognostic or Molecular Disparity Between Synchronous and Metachronous Metastases in Differentiated Thyroid Cancer: Insight From Middle Eastern Cohort | Biotech Hunter | Biotech Hunter